All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HEC88473Phase 21 trial

    Dongguan HEC Biopharmaceutical R&D Co., Ltd. · Type 2 Diabetes

  • HM15136Phase 21 trial

    Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism

  • HP-211Phase 21 trial

    Housey Healthcare ULC · Type 2 Diabetes

  • HRS-1301Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia

  • HRS-4029Phase 21 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke

  • HRS-7450Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke

  • HRS-9563Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension

  • IBI3016Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Hypertension

  • IlofotasePhase 21 trial

    AM-Pharma · Open Heart Surgery

  • INCA000585Phase 21 trial

    Incyte · Immune Thrombocytopenia

  • intraocular implant releasing timololTimoD implantPhase 21 trial

    EyeD Pharma · Glaucoma, Ocular Hypertension

  • INV-102Phase 21 trial

    Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy

  • 4TEEN4 Pharmaceuticals GmbH · Shock, Cardiogenic

  • ION775Phase 21 trial

    Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia

  • IW-6463CY6463, zagociguatPhase 21 trial

    Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

  • JBI-802Phase 21 trial

    Jubilant Therapeutics Inc. · Essential Thrombocythemia (ET), Polycythemia Vera

  • JK07Phase 21 trial

    Salubris Biotherapeutics Inc · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction

  • JMT202Phase 21 trial

    Shanghai JMT-Bio Inc. · Hypertriglyceridemia

  • JTT-861Phase 21 trial

    Shionogi Inc. · Chronic Heart Failure

  • KAI-7535Phase 21 trial

    Kailera · Obesity, Overweight

  • KBP-336Phase 21 trial

    KeyBioscience AG · Osteoarthritis in the Knee, Obesity

  • KELI-101Phase 21 trial

    Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery

  • LSALT PeptideMetablokPhase 21 trial

    Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery

  • LY3457263Phase 21 trial

    Eli Lilly · Type 2 Diabetes

  • LY3938577Phase 21 trial

    Eli Lilly · Diabetes Mellitus, Type 2

  • LY4086940Phase 21 trial

    Eli Lilly · Obesity, Overweight

  • MET233Phase 21 trial

    Pfizer · Obesity and Obesity-related Medical Conditions

  • MKP10241Phase 21 trial

    Mankind Pharma Limited · Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability

  • MLD10Phase 21 trial

    Pharmalyte Solutions LLC · Hypomagnesemia in Type 2 Diabetic Patients

  • MN-001Phase 21 trial

    MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease

  • MT200605Phase 21 trial

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke

  • MWX203Phase 21 trial

    Shanghai Minwei Biotechnology Co., Ltd · Mixed Dyslipidemia

  • NCS-01Phase 21 trial

    NC Medial Research Inc · Ischemic Stroke

  • NimacimabPhase 21 trial

    Skye Bioscience, Inc. · Obesity

  • NNC0662-3168Test product-APhase 21 trial

    Novo Nordisk · Overweight, Obesity, Type 2 Diabetes Mellitus

  • NoNO-42Phase 21 trial

    NoNO Inc. · Acute Ischemic Stroke

  • NST-1024Phase 21 trial

    NorthSea Therapeutics B.V. · High Triglycerides

  • NTS-521Phase 21 trial

    NeuroTrauma Sciences, LLC · Acute Ischemic Stroke

  • NVG-2089Phase 21 trial

    Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)

  • OPT101Phase 21 trial

    Op-T LLC · Type I Diabetes

  • OrticumabMLDL1278a, BI204Phase 21 trial

    Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation

  • OXU-001DEXAspheresPhase 21 trial

    Oxular Limited · Diabetic Macular Edema

  • PAL-119Phase 21 trial

    Paulex Bio Inc. · Healthy Volunteers and Diabetes Participants

  • PF-07328948Phase 21 trial

    Pfizer · Heart Failure

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • PF-07976016Phase 21 trial

    Pfizer · Obesity

  • PF-08653945Phase 21 trial

    Pfizer · Overweight, Obesity, Overweight and/or Obesity

  • PG043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • PKN605Phase 21 trial

    Novartis · Atrial Fibrillation

  • PN20Phase 21 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease

NewerPage 9 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.